BCL2 and head and neck squamous cell carcinoma: In this report, we show the synergistic effect of ABT-737, an inhibitor of anti-apoptotic Bcl-2 proteins, with radiation therapy which results in the radio-sensitization of HNSCC cell lines, including CSCs in vitro, and in vivo in a HNSCC xenograft model.